Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 The Rockefeller University » Michel C. Nussenzweig
2 Characterizing COVID-19 antibodies for potential treatments
3 Convergent antibody responses to SARS-CoV-2 in convalescent individuals
4 COVID-19 immunology study reveals universally effective antibodies
5 Scientists are using 'elite' antibodies from COVID-19 survivors to develop potent therapies
6 Rockefeller grants commercial license for the development of new HIV drugs
7 Michel C. Nussenzweig Wins 2016 Robert Koch Award
8 Michel C. Nussenzweig wins 2017 Sanofi-Institut Pasteur Award
9 Will SARS-CoV-2 escape future drugs by mutating? The answer may be a nuanced “no.”
10 Zoran Jankovic, a member of the Nussenzweig lab for nearly two decades, dies at 60
11 COVID-19 treatment could be ready by summer, researchers say
12 Early Immunological Studies Show Universally Effective Antibodies Against SARS-CoV-2 in Recovered Humans
13 Images of Antibodies as They Neutralize the COVID-19 Virus
14 Pew Biomed Scholar Shifts Her Focus to COVID-19
15 Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells
16 Ruth Nussenzweig, Who Pursued Malaria Vaccine, Dies at 89
17 Rockefeller University COVID-19 research receives additional $3M from Stavros Niarchos Foundation (SNF)
18 Blood from people who recover from coronavirus could provide a treatment
19 Rockefeller scientists launch a broad range of studies into novel coronavirus
20 Coronavirus Antibody Therapies Raise Hopes--and Skepticism
21 Gene-editing technique opens door for HIV vaccine
22 Sharpest New York minds join in quest to find a cure for the coronavirus
23 A Fresh Start, Back in Brazil, at 85
24 How toothless mock viruses could advance research on COVID-19
25 Harrington Discovery Institute Announces Award Recipients in its COVID-19 Rapid Response Initiative
26 In clinical trials, new antibody therapy controls HIV for months after treatment
27 COVID-19 Survivors Develop Neutralizing Antibodies but Might not be Enough to Block Reinfection: Study
28 Recommendations measuring persistent HIV reservoirs
29 The race to find a covid-19 drug in the blood of survivors
30 Taking stock
31 Researchers Identify Potent Infection-Blocking Antibodies In Race For COVID-19 Vaccine
32 Can you get coronavirus twice? Doctors are unsure, even as anecdotal reports mount.
33 The BEAT-HIV Martin Delaney Collaboratory Issues Recommendations on Measuring Persistent HIV Reservoirs in Cure-directed Clinical Trials
34 Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
35 Harrington Discovery Institute names award recipients in its Covid-19 initiative
36 Drug inspired by an old treatment could be the 'next big thing for Covid-19'
37 Emerging from the age of HIV : Seek
38 Can you catch the coronavirus twice? Here's what research says.
39 Rockefeller University COVID-19 Research Receives Additional $3M from SNF
40 Covid-19 scientific leaders share expertise in new MIT class
41 Researchers explore IgA response to SARS-CoV-2
42 Attention needs more attention : Seek
43 ‘Really Diabolical’: Inside the Coronavirus That Outsmarted Science
44 Universally Effective Antibodies Found in COVID-19 Patients Raise Hopes of Coronavirus Vaccine
45 A Serial Entrepreneur’s Quest To Save Lives After Saving His Own
46 bNAb May Hold the Key to HIV Cure, Vaccine
47 Findings shed new light on why Zika causes birth defects in some pregnancies
48 Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody
49 NIH launches study to test combination antibody treatment for HIV infection
50 This Free MIT Course Has Everything You Need To Know About COVID-19
51 Insight: Nobel winner's last big experiment: Himself
52 The Convergence of Science and Medicine
53 Sanofi and the Institut Pasteur reward five researchers in the service of human health
54 The microanatomic segregation of selection by apoptosis in the germinal center
55 One of 3 Chosen for Nobel in Medicine Died Days Ago (Published 2011)
56 Findings Shed New Light On Why Zika Causes Birth Defects In Some Pregnancies
57 Year in review: 10 science stories to remember
58 Training human antibodies to protect against HIV
59 New strategic plan will outline university priorities over five-year term
60 Scripps Research-led consortium awarded $129 million from NIH for new HIV vaccine approach
61 US Ambassador Pyatt Visits Greek Health Ministry, Praises SNF
62 "Elite" antibodies from COVID-19 survivors point to novel treatment
63 Genetically altered broadly neutralizing antibodies protect monkeys from HIV-like virus: NIAID scientists report single dose elicited long-term protection
64 Here’s what you need to know about fading coronavirus antibodies
65 'Magic Bullet' Antibody Can Suppress AIDS Virus
66 HIV antibodies that are worth the wait
67 Defining human dendritic cell progenitors by multiparametric flow cytometry
68 The Future of HIV Treatment Might Not Involve Pills
69 Latent HIV may lurk in 'quiet' immune cells, research suggests
70 Antibody combination puts HIV on the ropes
71 Cell division speeds up as part of antibody selection: Research reveals new details about the process by which the immune system refines its antibodies
72 Jeffrey V. Ravetch to receive 2018 Robert Koch Award
73 New antibody treatment controls HIV for months
74 A fight for life that united a field
75 New research helps explain why a deadly blood cancer often affects children with malaria: Immune responses to malaria-infected red blood cells appear to sometimes lead to cancer-promoting changes
76 Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
77 Immune Cells We Thought Were 'Useless' Are Actually a Weapon Against Infections Like HIV
78 Even mild coronavirus illness leads to antibodies: French study raises hope of immunity
79 Early intervention with new treatment enables durable control of HIV-like virus in monkeys
80 Scientists announce anti-HIV agent so powerful it can work in a vaccine
81 Differential Antigen Processing by Dendritic Cell Subsets in Vivo
82 Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
83 Yellow fever vaccine modified to fight malaria
84 New therapy keeps HIV at bay without daily drug regimen, study says
85 Up to 5.6million people in England
86 Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells
87 Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
88 A new role for a critical DNA repair molecule in the immune system
89 Evaluating strategies for HIV vaccination
90 Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies
91 Exclusive: Scientists tell U.S.
92 Birth Defects Caused By The Zika Virus Depend On The Mother's Immune Response
93 Research Areas and Laboratories
94 Table of Contents
95 Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies
96 Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs
97 Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs
98 Neutralizing HIV
99 Handful of 20-year HIV survivors hold key to discovering vaccine
100 Al fresco Britannia! Restaurants, pubs and cafés prepare for outdoor-dining revolution